Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DR26FJPP1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,727
Award facts
- Contract value 100% obligated
- $7,727.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm-fixed-price delivery order with a ceiling value of $7,727.36 to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 29, 2026, for NUCALA 100 MG/ML auto-injectors. The order was issued with no set-aside. Place of performance is Park Ridge, Illinois 60068, and the ultimate completion date is July 30, 2026.
Quick answers
Who was awarded contract SPE2DR26FJPP1?
SPE2DR26FJPP1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2026.
How much is contract SPE2DR26FJPP1 worth?
The government has obligated $7,727 on SPE2DR26FJPP1.
Is contract SPE2DR26FJPP1 an order under another contract?
Yes. SPE2DR26FJPP1 is a delivery order under SPE2DR25D9226, an indefinite delivery contract.
Was contract SPE2DR26FJPP1 competed?
The extent of competition for SPE2DR26FJPP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award